![Johan Lannebo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Johan Lannebo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Lannebo Fonder AB
![]() Lannebo Fonder AB Investment ManagersFinance Lannebo Fonder AB (Lannebo) is an independent fund management firm headquartered in Stockholm, Sweden. The firm was founded in 2000 by Anders Lannebo together with a group of portfolio managers from fund management companies of Nordic banks. Lannebo manages a range of Swedish mutual funds for individuals and institutional clients. Lannebo Fonder is a socially responsible investor and a signatory to the United Nations-supported Principles for Responsible Investment (UNPRI). | Voorzitter | 01-01-2000 | - |
Oprichter | 01-01-2000 | - | |
Portefeuillebeheerder-Aandelen | 01-01-2000 | - |
Loopbaan van Johan Lannebo
Eerdere bekende functies van Johan Lannebo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RECIPHARM AB (PUBL) | Directeur/Bestuurslid | 10-05-2017 | - |
Statistieken
Internationaal
Zweden | 3 |
Operationeel
Chairman | 1 |
Founder | 1 |
Portfolio Manager-Equities | 1 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Lannebo Fonder AB
![]() Lannebo Fonder AB Investment ManagersFinance Lannebo Fonder AB (Lannebo) is an independent fund management firm headquartered in Stockholm, Sweden. The firm was founded in 2000 by Anders Lannebo together with a group of portfolio managers from fund management companies of Nordic banks. Lannebo manages a range of Swedish mutual funds for individuals and institutional clients. Lannebo Fonder is a socially responsible investor and a signatory to the United Nations-supported Principles for Responsible Investment (UNPRI). | Finance |
Recipharm AB
![]() Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
- Beurs
- Insiders
- Johan Lannebo
- Ervaring